Angiotensin I converting enzyme activity inhibiting oligopeptides as well as preparation method and application thereof
A technique for inhibiting angiotensin and enzyme activity, which is applied in the fields of cardiovascular system diseases, peptides, fermentation, etc., to achieve high safety, reduce high blood pressure, and have no toxic and side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment example
[0027] 1. Intravenous injection animal experiments
[0028] Select 20 spontaneously hypertensive rats (SHR) as the experimental model. After the rats are fed for one week, they are divided into 2 groups, each with 10 rats. 20mg / kg dose was injected intravenously, and the results showed that the blood pressure of SHR in the control group continued to rise after 1 week, while the blood pressure of SHR in the treatment group dropped significantly, and the average systolic blood pressure of SHR dropped from 195mmHg to 162mmHg, indicating that this peptide has obvious blood pressure lowering effect .
[0029] 2. Animal experiment by gavage
[0030] Select 20 SHRs as the experimental model, and after feeding them for a week, divide them into groups, and inject the oligopeptide of the embodiment of the present invention into the stomach according to the dose of Thr Lys Thr Tyr Phe Pro His Phe of SHR body weight 20-200mg / kg every day, the results show that , 4 weeks later, the blood...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com